Interested in catching up on antiplatelet therapy for stroke prevention? Don't miss this webinar!
Wed. Sep. 22, 2021
19:00 - 20:30 EDT
Join us at this second in a new series of CSC-hosted webinars:
Antiplatelet (Plus) Therapy for Secondary Stroke Prevention: Past, Present, and Future
Target Audience:
Stroke neurologists and other physicians involved in secondary stroke prevention.
Other healthcare professionals interested in this topic are also welcome to attend.
Learning Objectives:
At the end of the webinar, participants will be able to:
Review clinical trials on antiplatelet monotherapy after TIA and stroke.
Evaluate recent clinical trials employing dual antiplatelet therapy in secondary stroke prevention after high-risk TIA and minor stroke.
Individualize single vs dual antiplatelet therapy after TIA and stroke.
Review recent evidence on dual pathway inhibition in secondary stroke prevention.
Discuss the future of antiplatelet therapy and dual pathway inhibition in stroke prevention including factor XI inhibitor.
There is no charge to attend.
Advance registration is required.Registration is accessed from the CSC website.
Not yet registered on the CSC website? Click here to join now. Associate membership is complimentary.
Please forward to any colleagues who might be interested.
This program is developed by the Canadian Stroke Consortium and planned to achieve scientific integrity, objectivity, and balance. This program is made possible through an unrestricted educational grant from Bayer.
